welcome to berlin - ziekenhuisdirecteurs energy... · • further improved market position and...

Unrestricted © Siemens AG 2014 All rights reserved. http://siemens.com/energy/power-generation/gas-turbines

Welcome to Berlin Geert De Gucht, Carl Laurent, Petra Michalke

Unrestricted © Siemens AG 2014.

Agenda

14.00 Welcome

14.15 Portfolio Siemens Healthcare; G. De Gucht, C. Laurent

14.45 Siemens Power Generation; P. Michalke

15.25 Shop tour in two groups; P. Michalke, H. Stavorinus

16.30 Q&A

16.45 Good-bye

Unrestricted © Siemens AG 2014. Answers for life.

Siemens – Healthcare IT & Portfolio


Siemens-Cerner Announcement – August 6th, 2014

1

2

Cerner plans to take over Siemens’ Health Services unit, encompassing the Hospital Information Systems (HIS) business

• Further improved market position and expertise – positive perspective for HS employees and customers

• Increased quality of Healthcare's core portfolio

Siemens Healthcare and Cerner enter into a strategic alliance in the area of Next-Generation-Healthcare-IT

• Offers Siemens the option to collaborate in additional Next-Generation-Healthcare-IT areas, while concentrating on its strengths

Two elements of the Siemens – Cerner transaction


Cerner Footprint1) Siemens HS Footprint1)

Combined strengths

Siemens strong

not covered

Siemens present Cerner strong Cerner present

1) Source: Cerner Publications/KLAS, Siemens

Strong market position of combined business will benefit customers and employees

Cerner: • Strong growth (revenue CAGR of 12% between 2005-

2013) • Strong profitability • Currently #2 in market share according to KLAS (hospitals

>200 beds) Cerner + Siemens HS • Complementary footprint (U.S. and internationally) • Strong international product portfolio

One of the globally leading HIS providers with positive perspectives for … … Customers • Best-in-class portfolio • Ability to execute • Focus on healthcare

IT • > 15.000 client

facilities

… Employees • > 20.000 employees


Some details on the agreement

Process • Agreement is subject to regulatory approvals and expected to close in first

quarter of CY 2015

Products • The product bases will remain in place for the foreseeable future (at least for

10 years) • Products in scope for Belux Market : Soarian, Clinicom, ishMed OpenLink,

Share, Sense

Services • Cerner expects to utilize the Siemens services portfolio, including Customer

Managed Services & data centers

People • Cerner intends to retain the vast majority of the Siemens HS staff • Legal entities will be raised in the countries where Cerner is not yet present


Strengthened focus of Siemens Healthcare Our innovation is driven by customer needs

Clinical utility

Workflow efficiency

Cost efficiency

Lowest possible dose CT with “FORCE”

Breast cancer test (HER-2)

Congestive heart failure test (BNP)

MR for improved patient experience

Workflow-enabled Processing SYNGO

Lab automation Increased productivity with syngo TimCT

Doubling throughput PET/CT & PET/MR

Leading service and support excellence

Mobile X-ray system

Affordable ultrasound equipment

Hybrid rooms with lowest dose ARTIS Q

siemens.com/answers Unrestricted © Siemens AG 2014. All rights reserved.

Siemens Building Technologies The future is smart

Unrestricted © Siemens AG 2014. All rights reserved.

Fire safety

Security

Comfort

Energy efficiency

• Fire, smoke and gas detection • Evacuation • Extinguishing • Danger management

• Access control • Video surveillance • Intrusion detection

• Building management/automation • Heating, ventilation, air conditioning • Lighting and shading

• Energy Performance Contracting • Energy management • Energy consulting

For energy-efficient and safe buildings and infrastructures

Building Technologies - innovative portfolio to energy-efficient and safe buildings

Life

Cyc

le M

anag

emen

t

Restricted © Siemens Healthcare Diagnostics Inc. 2014 All rights reserved. Answers for life.

Shaping and Transforming Diagnostics Helping to Change Quality of Life for Generations to Come

Restricted © Siemens Healthcare Diagnostics Inc. 2014 All rights reserved.

Siemens Healthcare Global Forces Challenge Sustainability of Healthcare

Debt Crisis Access to Healthcare

Accountable Care

Demographic Change


Global Impact

Note: Excludes point-of-care (POC) testing (FY 2012)

Tests provided per year

>9 billion

Patients tested per year with chemistry and immunoassay tests

>800 million

Siemens Healthcare Diagnostics Impacting Millions of Lives Each Year


Did you know?

Laboratory services affect 60-70% of all critical clinical decisions, such as whether to admit, discharge and/or initiate therapy for a patient – but make up only 2-3% of the hospital’s budget in the U.S. and less than 2% of total health expenditures in most European countries.

Medical Device Spending vs. National Health Expenditures, 1989 - 2010

Sources: “Estimates of Medical Device Spending in the United States,” Prepared by Gerald Donahoe and Guy King, FSA, MAAA for AdvaMed, October 2012. “Laboratory Medicine: A National Status Report Prepared for CDC.” Prepared by the Lewin Group, under subcontract to Battelle Memorial Institute, May 2008. “The European IVD Market in 2010: Press Release”, EDMA, 2011.

In 2010, medical device spending in the U.S. totaled $156.3 billion, 6.0% of total national health expenditures. This % figure has remained essentially consistent since 1992.

Uniting Clinical and Workflow Excellence The Value of Diagnostics


WORKFLOW EXCELLENCE CLINICAL EXCELLENCE

Enhanced Efficiencies Enhanced Patient Outcomes

Siemens Answers Uniting Clinical and Workflow Excellence


Enabling physicians to provide optimal patient care

Clinical Excellence

Quality Novel assays

across disease states

Accurate results that enhance

clinical knowledge

Throughout the care continuum

Diagnosis

Treatment

Follow-up

Clinical Excellence Enhancing Patient Outcomes


Immunosuppressive Drugs & TDM

Infectious Diseases

Inflammation

Metabolic

Nephropathies

Nutritional Assessment

Pancreatic Disease

Reproductive Endocrinology

Thyroid

Hepatic Diseases Allergy

Bone Metabolism

Cancer

Coagulation Disorders

Diabetes

Drugs of Abuse/Toxicology

Growth

Anemia

Autoimmune/Rheumatoid

Cardiovascular

OTHER

RESPIRATORY

URINARY

SKELETAL

CIRCULATORY

DIGESTIVE

ENDOCRINE

REPRODUCTIVE

Clinical Excellence Powered by Over 900 Assays


D-dimer Assays • Choice of point-of-care assay on

Stratus® CS Acute Care™ system or INNOVANCE central lab assay; both aid in the diagnosis of venous thromboembolism

• Point-of-care assay turn around time as little as 14 minutes

Galectin-3 Assay* • Biomarker assay for use in

the management of heart failure patients

Free Light Chains Assay (FLC) • First monoclonal antibody used in

FLC methods for the screening and monitoring of multiple myeloma, allowing lot-to-lot consistency

HER-2/neu Assay • Yields important information

about response to therapy and disease progression in metastatic breast cancer

ADVIA Centaur® Syphilis Assay** • Consolidated infectious-disease

testing for increased productivity • Sensitive, specific detection of

treponemal antibodies VERSANT® HCV RNA 1.0 Assay • Aids in the diagnosis and

management of HCV-affected individuals

Cardiovascular Oncology Infectious Disease

*Under development. Not available for sale. **Not available for sale in the U.S.

Clinical Excellence Optimizing Outcomes in Critical Disease States


Challenges in diagnostics

Increase efficiency Manage with smaller budgets

Operate with fewer people

Workflow Excellence A Growing Need


High Troughput SYSTEMS

*Available outside U.S. only.

Workflow Excellence Evolution from Systems to Solutions

Unified solution to transform laboratory operations

• Peak performance

• Adaptability

• Intelligent technologies

• Siemens’ workflow expertise

High Troughput SOLUTIONS

http://creative.diagnostics.siemens.com/siemens_dx_images_product/ADVIA_Centaur_XP/detail.np/detail-01.html

http://creative.diagnostics.siemens.com/siemens_dx_images_product/BCS_XP/detail.np/detail-01.html


Medical Testing Center Changshu, China

“Siemens workflow solutions allowed our lab to double workload in the 1.5 years since installation, without adding staff.”

Workflow Excellence Automation and Workflow Solutions


Administrative Healthcare Manager, Chemical Pathology,

University of Michigan

“We’ve leaned out our processes and improved things with CentraLink. I haven’t seen on other systems the algorithms that CentraLink has for hepatitis and HIV reporting. In the outpatient group, we figured that we have cut our number of serum separator tube (SST) draws down by 60%.”

Workflow Excellence Diagnostics IT Solutions


Innovation in Healthcare

Syst

ems

Assa

ys

IT A

pplic

atio

ns

Syst

ems

Bio

mar

kers

Scan protocol: SPECT:20 mCi 99mTc-Cardiolite stress39 mCi 99mTc-Myoview restFlash 3D attenuation and scatter correctio

6 slice CT:81 eff. mAs130 kV3 mm collimation5 mm slice thicknes Corrected Stress

Clin

ical

App

licat

ions

In Vitro Diagnostics Imaging Information Technology

Knowledge-driven Healthcare

Information Connectivity Enables Knowledge-driven Healthcare




Driven by advanced Automation.

ECONOMICAL EXCELLENCE


May 2014

Guidance

Define objectives

Analysis and Simulation

HCS Observations

Floorplans

Financials

Project set-up and installation

Follow up


Simulation & Capacity-analysis

Test Total Test Total Test Total Test TotalBHCG__HCGTM 16 CFERRI 164 CFERRI 146 AAM2 15CKMB3 8 KFOLIU 101 KFOLIU 71 AAT3 8DHEAS 4 RTSH2 178 RTSH2 175 AFPR__AFPZW 1HATOT 10 T4VR 90 T4VR 105 CARBA 1HAVM 1 VB12 120 VB12 110 CEAD__CEAM 45HBCAS 5 Grand Total 653 Grand Total 607 CLH 13HBEAG 3 CORDX__8__20 7HBEAS 2 CPEP2 1HBSAG 8 DIGOX 2HBSAS 11 DIPHA 1HEPC2 10 INSUL 2HIV 22 KFSH 14KCA153 13 KIGE 17KESTRA 9 KPROG__PROGH 10MYOGL 2 KTESTO 2PTH2 3 PROLA2 4RUBG__RUBGZ 4 PSA__D60__D 112RUBM 1 PSAC 10TOXG3 7 T3VR 122TOXM 8 VALPRO 6TROPO2 11 Grand Total 393Grand Total 158

Centaur1 Centaur2 Centaur3 Centaur4


Actual versus simulated TAT


HCS Observations


HCS Observations : follow the tube


“Value Stream Mapping”

Load N = 5

Balance

Spin

Unload

PRE-ANALYTICAL PROCESS ANALYTICAL PROCESS POST ANALYTICAL PROCESS

Inspect Label Integrity

De-Cap

Load Analyzers

Analysis

Release Result

Unload Carrier

Rack

Re-Cap

Request

Sample Search

Transport

Transport

Triage Short

In-Pts EDOut-Pts Remote

PTS DELIVER

Register

Priority

Deliver

HematologyCoagulationChem/IA Urinalysis

InstrumentSort Centaur Integra

CNT

Hemolyzed

Rack

Transport

Pour

Re-Seat

Special Segment

Action

Sample Search

Aliquot

Store

Store

Add-On Send Out

Result

Central Processing

Pre-Sort to CPU Bench

LIS Receipt

Sort

Out Rack In Rack

CentrifugeStat

Pre-Sort to MPA

Pre-Sort to Stats

Aliquote

May 2014 Page 32

Optimized Flow

• Less manual steps

• Reduced waiting times

• Less manual tube handling

• Reduced walking distances

• Less aliquots

• Reduced error risk

• Reduced costs

• Less FTE’s

Optimized Sample

Flow


Floorplan design - 3D


Project set-up

MS project planning

Job descriptions

Autocad Technical plans


Installation


Process Control


© 2013 Siemens Healthcare Diagnostics.

Final Floorplan based on best flow


Floorplan design - 3D


Do not under- estimate change!


Review Meetings


Economical Excellence


Financial Model


Economical Excellence : critical factors

One supplier

Dependent on objectives

Future growth & devellopment plans

Openess to Change

Unrestricted © Siemens AG 2014 All rights reserved. http://siemens.com/energy/power-generation/gas-turbines

Welcome to Berlin Petra Michalke

Siemens Energy Sector – Gas Turbine Manufacturing & Service @ Berlin

Unrestricted © Siemens AG 2014 All rights reserved.

Page 46 Siemens Energy / E CC P GT BlnH September, 12th 2014 P. Michalke

Content

2

Arial 16 pt., Line spacing 1.1 lines 1

Gas Turbine Manufacturing Berlin

Siemens Energy Sector



As part of Siemens Energy we contribute to clean energy to the world

Instrumentation & Electrical (E F IE)

Conventional Island (E F CI)

Products (E F PR)

Energy Solutions (E F ES)

Energy Sector

Fossil Power Generation

Power Transmission Oil & Gas Energy Service Wind

Power

Fossil Power

Generation

Business Unit Products

I&C* Sector Energy Sector Industry Sector Healthcare Sector

* Infrastructure and Cities Sector

Gas Turbines

Steam Turbines Generators Fuel Gasifier

Energy Service (E S SF)



Enhancement of Gas Turbine Operational Flexibility Introduction

Base Load (Original Design Concept)

Top Priorities: Power Efficiency Availability

Classical Operation

Economical, Population & Political Requirements

Intermediate (Environmental Adaptions)

Top Priorities: Efficiency (CHP) Emissions Seasonal

Availability

Interim Operation

Carbon Allowances

Coal Power

Combined Cycle Power Plant

Top Priorities: Flexibility O&M Costs Emissions

Grid Code Requirements & Forecast Volatility

Today‘s* & Future Operation

Standby (Low hours, fast responses)

*global and local variations



Enhancement of Gas Turbine Operational Flexibility with Flex-Power Services™

Hot Start Conditions & Purge Credit

Base Load (P*)

Secondary Frequency Response

Peak Load & Grid Support

Minimum Load

Improvement

Fast Shut &

Cool Down

Fast Start Up

Primary Frequency Response

Standard Operation Line

Flex Operation Line



Content

2

Arial 16 pt., Line spacing 1.1 lines 1

Gas Turbine Manufacturing Berlin

Siemens Energy Sector



Gas Turbine Manufacturing Plant

Berlin Plant Huttenstraße

Port Westhafen (Assembly & Depot) Mertensstraße

(Depot)

Borsighalle 20 (Manufacturing & Depot)

Siemensstadt (Service, TACR, Manufacturing & Depot)

Ludwigsfelde Energy Logistics Center & CEC



Berlin Plant “Huttenstrasse”

■ 130,000 m² plant area

■ 68,700 m² built-up

■ About 65% under crane coverage

■ 200 customer visits / year



Berlin Plant: Staff Structure

Berlin Plant (Manufacturing and Service)

Employees

3,700

Women Proportion

19 %

Number of Nationalities

46

Proportion of non-German Employees

6 %

Apprentice

250



Shipment of 800th gas turbine

Berlin Plant: History

Foundation of turbine factory

50 MW – World largest

steam turbine

Foundation KWU

First gas turbine 62.5 MW (V93.0)

Worlds most powerful gas turbine

116 MW (V94.1)

Launch of V94.2

(SGT5-2000E)

Launch of V94.3A

(SGT5-4000F)

Merger with Westinghouse

Worlds most powerful gas turbine 375 MW

(SGT5-8000H)

Steam turbine manufacturing Global manufacturing network Gas turbine manufacturing

Opening of Field Service

Training Centre

1904 1916 1969 1972 1978 1981

1996 1998 2000 2010 2011 2013

Start of global manufacturing



Large Scale Siemens Gas Turbines: The Right Engine for Every Power Category

50 H

z

SGT5-8000H

SGT5-4000F

SGT5-2000E

307 MW

172 MW

400 MW

SGT6-8000H

114 MW

SGT6-5000F

SGT6-2000E

274 MW

232 MW

60 H

z



The Heart of a Power Plant: Siemens Heavy Duty Gas Turbine

We generate customer benefit

• Highest reliability: over 99 %

• Highest availability: over 95 %

• Power output between 114 and 400 MW

• Highest efficiency: over 40 %

• Environmental friendliness with lowest emission values

• Flexibility

Proven Technology > 950 GTs Operating in 60 Countries



Products Berlin Plant

SGT6-2000E, SGT5-2000E

SGT6-8000H, SGT5-8000H Service Components

SGT5-4000F SGT6-5000F



Siemens products to ensure Customer’s success and Competitiveness!

• Excellent product portfolio available regarding diverse market requirements.

• Product validation

• Operational experience ensure high reliability.

• Continuous product development to reflect customer’s needs.

• Siemens as Original Equipment Manufacturer (OEM) takes care!

Summary & Conclusion



Shop Tour Berlin Plant

Combustion System

Final Assembly

Blade Shop Auxiliaries

Rotor Shop



Disclaimer

This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified either orally or in writing by words as “expects”, “anticipates”, “intends”, “plans”, “believes”, “seeks”, “estimates”, “will” or words of similar meaning. Such statements are based on our current expectations and certain assumptions, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond Siemens’ control, affect its operations, performance, business strategy and results and could cause the actual results, performance or achievements of Siemens worldwide to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For us, particular uncertainties arise, among others, from changes in general economic and business conditions, changes in currency exchange rates and interest rates, introduction of competing products or technologies by other companies, lack of acceptance of new products or services by customers targeted by Siemens worldwide, changes in business strategy and various other factors. More detailed information about certain of these factors is contained in Siemens’ filings with the SEC, which are available on the Siemens website, www.siemens.com and on the SEC’s website, www.sec.gov. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the relevant forward-looking statement as anticipated, believed, estimated, expected, intended, planned or projected. Siemens does not intend or assume any obligation to update or revise these forward-looking statements in light of developments which differ from those anticipated.

Trademarks mentioned in this document are the property of Siemens AG, it's affiliates or their respective owners.

http://www.siemens.com/

http://www.sec.gov/

welcome to berlin - ziekenhuisdirecteurs energy... · • further improved market position and...

Documents